A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation

Neurology. 2004 Jul 13;63(1):57-65. doi: 10.1212/01.wnl.0000132979.08394.6d.

Abstract

Background: Benign familial neonatal convulsion (BFNC) is a rare autosomal dominant disorder caused by mutations in two genes, KCNQ2 and KCNQ3, encoding for potassium channel subunits underlying the M-current. This current limits neuronal hyperexcitability by causing spike-frequency adaptation.

Methods: The authors describe a BFNC family with four affected members: two of them exhibit BFNC only while the other two, in addition to BFNC, present either with a severe epileptic encephalopathy or with focal seizures and mental retardation.

Results: All affected members of this family carry a novel missense mutation in the KCNQ2 gene (K526N), disrupting the tri-dimensional conformation of a C-terminal region of the channel subunit involved in accessory protein binding. When heterologously expressed in CHO cells, potassium channels containing mutant subunits in homomeric or heteromeric configuration with wild-type KCNQ2 and KCNQ3 subunits exhibit an altered voltage-dependence of activation, without changes in intracellular trafficking and plasma membrane expression.

Conclusion: The KCNQ2 K526N mutation may affect M-channel function by disrupting the complex biochemical signaling involving KCNQ2 C-terminus. Genetic rather than acquired factors may be involved in the pathophysiology of the phenotypic variability of the neurologic symptoms associated with BFNC in the described family.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Amino Acid Substitution*
  • Animals
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Drug Resistance / genetics
  • Epilepsies, Partial / drug therapy
  • Epilepsies, Partial / genetics
  • Epilepsy, Benign Neonatal / drug therapy
  • Epilepsy, Benign Neonatal / genetics*
  • Female
  • Humans
  • Infant, Newborn
  • Intellectual Disability / genetics*
  • Ion Channel Gating
  • Ion Transport
  • KCNQ2 Potassium Channel
  • Magnetic Resonance Imaging
  • Male
  • Molecular Sequence Data
  • Mutation, Missense*
  • Pedigree
  • Phenotype
  • Point Mutation*
  • Potassium Channels, Voltage-Gated / chemistry
  • Potassium Channels, Voltage-Gated / genetics*
  • Potassium Channels, Voltage-Gated / physiology
  • Protein Conformation
  • Protein Subunits
  • Quadriplegia / genetics
  • Structure-Activity Relationship

Substances

  • Anticonvulsants
  • KCNQ2 Potassium Channel
  • KCNQ2 protein, human
  • Potassium Channels, Voltage-Gated
  • Protein Subunits